Answers are grounded in this paper and cite their sources.
Molecular and transcription factor subtyping were recently introduced to identify patients with unique clinical features in small cell lung cancer (SCLC). However, its prognostic relevance is yet to be established. This study aims to investigate the clinical implications and prognostic significance of transcription factor subtyping in SCLC using immunohistochemistry.
No takes yet. Share an insight, caveat, or question.
Go et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: